Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections (CADISP)
Recruitment status was Active, not recruiting
| Tracking Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | April 8, 2008 | ||||||||||||
| Last Updated Date | October 20, 2009 | ||||||||||||
| Start Date ICMJE | July 2005 | ||||||||||||
| Primary Completion Date | January 2009 (final data collection date for primary outcome measure) | ||||||||||||
| Current Primary Outcome Measures ICMJE |
association of genetic polymorphisms with cervical artery dissections [ Time Frame: 2009 ] [ Designated as safety issue: No ] | ||||||||||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||||||||||
| Change History | Complete list of historical versions of study NCT00657969 on ClinicalTrials.gov Archive Site | ||||||||||||
| Current Secondary Outcome Measures ICMJE |
|
||||||||||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||||||
| Descriptive Information | |||||||||||||
| Brief Title ICMJE | Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections | ||||||||||||
| Official Title ICMJE | Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections | ||||||||||||
| Brief Summary | The main purpose of this study is to look for genetic and environmental risk factors of cervical artery dissections, a major cause of ischemic stroke in young adults, in a large multicenter case-control trial |
||||||||||||
| Detailed Description | Background: Cervical artery dissections (CAD) are a major cause of ischemic stroke, longstanding disability, and occasionally death in young adults. Several lines of evidence suggest genetic predisposition for CAD. Previous genetic studies were, however, inconclusive mainly due to insufficient numbers of patients. Our hypothesis is that CAD is a multifactorial disease caused by yet largely unidentified genetic variants and environmental factors, which may interact. Aim: Our main aim is to look for genetic and environmental risk factors and gene-environment interactions potentially underlying CAD. In addition, therapeutic aspects are addressed in the setting of a multicenter registry. Methods: We organized a multinational European network, CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) which targets at increasing our knowledge on the pathophysiological mechanisms of this disease in a large, representative patient population. Within this network, we are aiming to perform a de novo genetic association analysis using both a genome-wide and a candidate gene approach. For this purpose, 1130 patients with CAD, 1130 patients with non-CAD ischemic stroke, and 1890 healthy controls are being recruited, and detailed clinical, laboratory, diagnostic, therapeutic and outcome data are being collected from all participating patients. We are expecting to reach the above numbers of subjects by the end of 2008. Analyses of the CADISP database might clarify a number of debated issues, including risk factors, stroke preventive treatment, and outcome predictors of CAD. We present the strategy of a collaborative project searching for genetic risk factors of cervical artery dissections. We hope that the CADISP network will provide detailed and novel data on risk factors and treatment aspects of CAD. |
||||||||||||
| Study Type ICMJE | Observational | ||||||||||||
| Study Design ICMJE | Observational Model: Case Control | ||||||||||||
| Target Follow-Up Duration | Not Provided | ||||||||||||
| Biospecimen | Retention: Samples With DNA Description: DNA, plasma, serum |
||||||||||||
| Sampling Method | Non-Probability Sample | ||||||||||||
| Study Population | groups 1 and 2: hospital-based, neurology departments group 3: community samples |
||||||||||||
| Condition ICMJE |
|
||||||||||||
| Intervention ICMJE | Not Provided | ||||||||||||
| Study Group/Cohort (s) |
|
||||||||||||
| Publications * |
|
||||||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||||||
| Recruitment Information | |||||||||||||
| Recruitment Status ICMJE | Active, not recruiting | ||||||||||||
| Enrollment ICMJE | 4169 | ||||||||||||
| Estimated Completion Date | September 2009 | ||||||||||||
| Primary Completion Date | January 2009 (final data collection date for primary outcome measure) | ||||||||||||
| Eligibility Criteria ICMJE | GROUP1: Inclusion Criteria:
Exclusion Criteria:
GROUP2: Inclusion Criteria:
Exclusion Criteria:
GROUP3: Inclusion criteria:
|
||||||||||||
| Gender | Both | ||||||||||||
| Ages | 18 Years and older | ||||||||||||
| Accepts Healthy Volunteers | No | ||||||||||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||||||||
| Location Countries ICMJE | Argentina, Belgium, Finland, France, Germany, Italy, Switzerland, Turkey, United Kingdom | ||||||||||||
| Administrative Information | |||||||||||||
| NCT Number ICMJE | NCT00657969 | ||||||||||||
| Other Study ID Numbers ICMJE | CADISP | ||||||||||||
| Has Data Monitoring Committee | Not Provided | ||||||||||||
| Responsible Party | Dr. S Debette, Dr. C Grond-Ginsbach, Pr. D Leys, University Hospitals of Heidelberg and Lille | ||||||||||||
| Study Sponsor ICMJE | Cervical Artery Dissections and Ischemic Stroke Patients - Consortium | ||||||||||||
| Collaborators ICMJE | Not Provided | ||||||||||||
| Investigators ICMJE |
|
||||||||||||
| Information Provided By | Cervical Artery Dissections and Ischemic Stroke Patients - Consortium | ||||||||||||
| Verification Date | October 2009 | ||||||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||||||